Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trial
- DOI
- 10.1016/s1473-3099(26)00492-5
- Published
- 2026-11
- Container
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s1473-3099-26-00492-5,
title = {Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trial},
author = {Bakary Fofana and Rella Zoleko-Manego and Ghyslain Mombo-Ngoma and Andre Toure Offianan and Mulenge Kilowele and Amadou Hamidou Togo and Jean Moïse T Kaboré and Souleymane Dama and Oumar Bila Traore and Peter G Kremsner and Rakiswendé Serge Yerbanga and Mohamed Boly and Kanga Didier N’guetta and Waota Guy Matthieu Toure and Franck Sango and Martel Ngoy Musodi and Anne Claire Marrast and Stephan Duparc and Myriam El-Gaaloul and Cornelis Winnips and Celine Risterucci and Saneesh Kumar and Guoqin Su and Gen Zhu and Jared Thornton and Ramachandra Sangana and Jayant Sancheti and Hira Choudhury and Zhiyan Qian and Alassane Dicko and Issaka Sagara and Jean Bosco Ouedraogo and Sodiomon Bienvenu Sirima and Martin Peter Grobusch and Abdoulaye Djimde},
year = {2026},
journal = {The Lancet Infectious Diseases},
doi = {10.1016/s1473-3099(26)00492-5},
url = {https://doi.org/10.1016/s1473-3099(26)00492-5}
}RIS
TY - JOUR TI - Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trial AU - Bakary Fofana AU - Rella Zoleko-Manego AU - Ghyslain Mombo-Ngoma AU - Andre Toure Offianan AU - Mulenge Kilowele AU - Amadou Hamidou Togo AU - Jean Moïse T Kaboré AU - Souleymane Dama AU - Oumar Bila Traore AU - Peter G Kremsner AU - Rakiswendé Serge Yerbanga AU - Mohamed Boly AU - Kanga Didier N’guetta AU - Waota Guy Matthieu Toure AU - Franck Sango AU - Martel Ngoy Musodi AU - Anne Claire Marrast AU - Stephan Duparc AU - Myriam El-Gaaloul AU - Cornelis Winnips AU - Celine Risterucci AU - Saneesh Kumar AU - Guoqin Su AU - Gen Zhu AU - Jared Thornton AU - Ramachandra Sangana AU - Jayant Sancheti AU - Hira Choudhury AU - Zhiyan Qian AU - Alassane Dicko AU - Issaka Sagara AU - Jean Bosco Ouedraogo AU - Sodiomon Bienvenu Sirima AU - Martin Peter Grobusch AU - Abdoulaye Djimde PY - 2026 JO - The Lancet Infectious Diseases DO - 10.1016/s1473-3099(26)00492-5 UR - https://doi.org/10.1016/s1473-3099(26)00492-5 ER -
APA
Fofana, B., Zoleko-Manego, R., Mombo-Ngoma, G., Offianan, A. T., Kilowele, M., Togo, A. H., Kaboré, J. M. T., Dama, S., Traore, O. B., Kremsner, P. G., Yerbanga, R. S., Boly, M., N’guetta, K. D., Toure, W. G. M., Sango, F., Musodi, M. N., Marrast, A. C., Duparc, S., El-Gaaloul, M., Winnips, C., Risterucci, C., Kumar, S., Su, G., Zhu, G., Thornton, J., Sangana, R., Sancheti, J., Choudhury, H., Qian, Z., Dicko, A., Sagara, I., Ouedraogo, J. B., Sirima, S. B., Grobusch, M. P., & Djimde, A. (2026). Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(26)00492-5
Source records
- crossref · retrieved 2026-11-08T02:56:36.755Z